Geode Capital Management
TEVA icon

Geode Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Geode Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316M Buy
10,564,988
+238,484
+2% +$7.67M 0.02% 569
2025
Q4 		$320M Buy
10,326,504
+336,629
+3% +$8.29M 0.02% 556
2025
Q3 		$200M Buy
9,989,875
+360,349
+4% +$6.33M 0.01% 701
2025
Q2 		$160M Buy
9,629,526
+434,918
+5% +$7.02M 0.01% 752
2025
Q1 		$141M Sell
9,194,608
-86,444
-0.9% -$1.54M 0.01% 783
2024
Q4 		$204M Buy
9,281,052
+489,041
+6% +$8.9M 0.02% 632
2024
Q3 		$158M Buy
8,792,011
+291,124
+3% +$5.1M 0.01% 721
2024
Q2 		$138M Buy
8,500,887
+398,165
+5% +$6.13M 0.01% 739
2024
Q1 		$114M Buy
8,102,722
+323,737
+4% +$4.08M 0.01% 844
2023
Q4 		$80.9M Buy
7,778,985
+283,206
+4% +$2.64M 0.01% 1002
2023
Q3 		$76.2M Buy
7,495,779
+349,180
+5% +$3.25M 0.01% 940
2023
Q2 		$53.6M Buy
7,146,599
+394,037
+6% +$3.2M 0.01% 1196
2023
Q1 		$59.6M Buy
6,752,562
+207,161
+3% +$2.05M 0.01% 1070
2022
Q4 		$59.5M Sell
6,545,401
-87,713
-1% -$765K 0.01% 1035
2022
Q3 		$53.4M Buy
6,633,114
+314,715
+5% +$2.78M 0.01% 1032
2022
Q2 		$47.4M Buy
6,318,399
+230,504
+4% +$2.01M 0.01% 1173
2022
Q1 		$57M Buy
6,087,895
+158,493
+3% +$1.32M 0.01% 1157
2021
Q4 		$47.3M Buy
5,929,402
+207,724
+4% +$1.87M 0.01% 1354
2021
Q3 		$55.5M Buy
5,721,678
+534,109
+10% +$5M 0.01% 1187
2021
Q2 		$51.2M Buy
5,187,569
+486,108
+10% +$5.15M 0.01% 1285
2021
Q1 		$54.1M Sell
4,701,461
-208,644
-4% -$2.39M 0.01% 1166
2020
Q4 		$47.2M Buy
4,910,105
+580,306
+13% +$5.56M 0.01% 1136
2020
Q3 		$38.9M Buy
4,329,799
+7,540
+0.2% +$79.8K 0.01% 1061
2020
Q2 		$53.2M Buy
4,322,259
+36,558
+0.9% +$413K 0.01% 862
2020
Q1 		$38.4M Buy
4,285,701
+28,019
+0.7% +$287K 0.01% 906
2019
Q4 		$41.6M Buy
4,257,682
+87,581
+2% +$782K 0.01% 1058
2019
Q3 		$28.6M Buy
4,170,101
+357,325
+9% +$2.74M 0.01% 1239
2019
Q2 		$35.1M Buy
3,812,776
+560,511
+17% +$6.76M 0.01% 1090
2019
Q1 		$50.9M Buy
3,252,265
+125,681
+4% +$2.22M 0.01% 830
2018
Q4 		$48.1M Buy
3,126,584
+279,286
+10% +$5.73M 0.01% 757
2018
Q3 		$61.2M Buy
2,847,298
+149,549
+6% +$3.47M 0.02% 712
2018
Q2 		$65.5M Buy
2,697,749
+214,920
+9% +$4.38M 0.02% 643
2018
Q1 		$42.3M Buy
2,482,829
+170,611
+7% +$3.33M 0.01% 813
2017
Q4 		$43.7M Buy
2,312,218
+93,175
+4% +$1.4M 0.01% 772
2017
Q3 		$39M Buy
2,219,043
+33,181
+2% +$747K 0.01% 795
2017
Q2 		$72.5M Buy
2,185,862
+325,436
+17% +$10.1M 0.03% 538
2017
Q1 		$59.6M Buy
1,860,426
+134,577
+8% +$4.59M 0.02% 573
2016
Q4 		$62.5M Buy
1,725,849
+1,527,413
+770% +$61M 0.03% 532
2016
Q3 		$9.13M Buy
198,436
+18,838
+10% +$983K ﹤0.01% 1557
2016
Q2 		$9.02M Buy
179,598
+3,064
+2% +$163K ﹤0.01% 1510
2016
Q1 		$9.45K Sell
176,534
-7,401
-4% -$434K 0.01% 1440
2015
Q4 		$12.1M Buy
183,935
+1,787
+1% +$110K 0.01% 1228
2015
Q3 		$10.3M Sell
182,148
-6,784
-4% -$440K 0.01% 1318
2015
Q2 		$11.2M Buy
188,932
+11,221
+6% +$692K 0.01% 1336
2015
Q1 		$11.1M Buy
177,711
+29,110
+20% +$1.69M 0.01% 1311
2014
Q4 		$8.54M Buy
148,601
+25,106
+20% +$1.4M 0.01% 1460
2014
Q3 		$6.64M Buy
123,495
+24,416
+25% +$1.29M ﹤0.01% 1578
2014
Q2 		$5.19M Buy
99,079
+23,688
+31% +$1.21M ﹤0.01% 1768
2014
Q1 		$3.98M Buy
75,391
+23,670
+46% +$1.09M ﹤0.01% 1918
2013
Q4 		$2.07M Sell
51,721
-4,311
-8% -$170K ﹤0.01% 2269
2013
Q3 		$2.12M Buy
56,032
+8,368
+18% +$326K ﹤0.01% 2135
2013
Q2 		$1.87M Buy
+47,664
New +$1.86M ﹤0.01% 2079

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management's TEVA Position: Q1 2026 in Review

Geode Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 2.3% in Q1 2026, buying an estimated $7.67M and bringing the position to 10,564,988 shares worth $316M. The position accounts for 0.02% of the portfolio, ranked #569.

Geode Capital Management first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $320M in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Geode Capital Management held 10,564,988 shares of Teva Pharmaceuticals worth $316M as of Q1 2026.
  • Geode Capital Management bought 238,484 Teva Pharmaceuticals shares in Q1 2026, an estimated $7.67M.
  • Teva Pharmaceuticals made up 0.02% of Geode Capital Management's portfolio in Q1 2026, its #569 holding.
  • Geode Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Teva Pharmaceuticals position peaked at $320M in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.